{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:41:28Z","timestamp":1792687288360,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jconrel.2023.07.031","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T12:49:11Z","timestamp":1690980551000},"page":"87-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Poly(vinyl pyrrolidone) derivatives as PEG alternatives for stealth, non-toxic and less immunogenic siRNA-containing lipoplex delivery"],"prefix":"10.1016","volume":"361","author":[{"given":"Manon","family":"Berger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Toussaint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaa Ben","family":"Djemaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Laloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Pendeville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Evrard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Jer\u00f4me","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lechanteur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Mottet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Debuigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine","family":"Piel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2023.07.031_bb0005","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jconrel.2021.03.043","article-title":"The dawn of mRNA vaccines: the COVID-19 case","volume":"333","author":"Verbeke","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.07.031_bb0010","doi-asserted-by":"crossref","first-page":"120586","DOI":"10.1016\/j.ijpharm.2021.120586","article-title":"mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability","volume":"601","author":"Schoenmaker","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120851","article-title":"Innovative lipoplexes formulations with enhanced siRNA efficacy for cancer treatment: where are we now?","volume":"605","author":"Berger","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.tips.2019.10.009","article-title":"Oligonucleotides to the (gene) rescue: FDA approvals 2017\u20132019","volume":"41","author":"R\u00fcger","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0025","article-title":"Therapeutic siRNA: state of the art","volume":"5","author":"Hu","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15020597","article-title":"Effect of PEG anchor and serum on lipid nanoparticles: development of a nanoparticles tracking method","volume":"15","author":"Berger","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2023.07.031_bb0035","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0040","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/mt.2013.57","article-title":"Gene silencing via RNAi and siRNA quantification in tumor tissue using MEND, a liposomal siRNA delivery system","volume":"21","author":"Sakurai","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0045","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jconrel.2020.03.022","article-title":"Evasion of the accelerated blood clearance phenomenon by polysarcosine coating of liposomes","volume":"322","author":"Son","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.07.031_bb0050","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1021\/acs.bioconjchem.0c00366","article-title":"The biomolecular Corona of lipid nanoparticles for gene therapy","volume":"31","author":"Francia","year":"2020","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0055","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.2147\/IJN.S129300","article-title":"Protein corona: a new approach for nanomedicine design","volume":"12","author":"Nguyen","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.07.031_bb0060","first-page":"4183","article-title":"Effects of PEG anchors in PEGylated siRNA lipoplexes on in vitro gene-silencing effects and siRNA biodistribution in mice","volume":"22","author":"Hattori","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0065","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","article-title":"Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals","volume":"154\u2013155","author":"Kozma","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0070","article-title":"Suspicions grow that nanoparticles in Pfizer's COVID-19 vaccine trigger rare allergic reactions","author":"De Vrieze","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2023.07.031_bb0075","article-title":"The importance of poly(ethylene glycol) alternatives for overcoming PEG immunogenicity in drug delivery and bioconjugation","volume":"12","author":"Thi","year":"2020","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.jconrel.2023.07.031_bb0080","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijpharm.2013.07.059","article-title":"Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration","volume":"456","author":"Abu Lila","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2015.06.023","article-title":"The effect of polymer backbone chemistry on the induction of the accelerated blood clearance in polymer modified liposomes","volume":"213","author":"Kierstead","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.07.031_bb0090","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3390\/pharmaceutics5040542","article-title":"Surface engineering of liposomes for stealth behavior","volume":"5","author":"Nag","year":"2013","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2023.07.031_bb0095","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-020-01909-4","article-title":"Multifunctional role of polyvinylpyrrolidone in pharmaceutical formulations","volume":"22","author":"Luo","year":"2021","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2023.07.031_bb0100","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.addr.2020.07.020","article-title":"Polymer nanomedicines","volume":"156","author":"Kope\u010dek","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0105","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.addr.2020.09.009","article-title":"Polymeric micelles for the delivery of poorly soluble drugs: from nanoformulation to clinical approval","volume":"156","author":"Hwang","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0110","doi-asserted-by":"crossref","first-page":"102046","DOI":"10.1016\/j.jddst.2020.102046","article-title":"Pharmaceutical assessment of polyvinylpyrrolidone (PVP): as excipient from conventional to controlled delivery systems with a spotlight on COVID-19 inhibition","volume":"60","author":"Kurakula","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2020.109919","article-title":"Moving polyvinyl pyrrolidone electrospun nanofibers and bioprinted scaffolds toward multidisciplinary biomedical applications","volume":"136","author":"Kurakula","year":"2020","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0120","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev-chembioeng-073009-100847","article-title":"Polymers for drug delivery systems","volume":"1","author":"Liechty","year":"2010","journal-title":"Annu. Rev. Chem. Biomol. Eng."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0125","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1016\/S0142-9612(01)00050-3","article-title":"Amphiphilic poly-N-vinylpyrrolidones: synthesis, properties and liposome surface modification","volume":"22","author":"Torchilin","year":"2001","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.07.031_bb0130","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1134\/S0003683808060112","article-title":"Novel liposomal forms of antifungal antibiotics modified by amphiphilic polymers","volume":"44","author":"Yamskov","year":"2008","journal-title":"Appl. Biochem. Microbiol."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2016.11.056","article-title":"Preparation, characterization and in vivo pharmacokinetic study of PVP-modified oleanolic acid liposomes","volume":"517","author":"Liu","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0140","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijpharm.2015.02.041","article-title":"Development of anti-E6 pegylated lipoplexes for mucosal application in the context of cervical preneoplastic lesions","volume":"483","author":"Lechanteur","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0145","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1021\/acs.molpharmaceut.6b01154","article-title":"Promoting vaginal distribution of E7 and MCL-1 siRNA-silencing nanoparticles for cervical cancer treatment","volume":"14","author":"Lechanteur","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0150","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ejps.2016.08.058","article-title":"PEGylation of lipoplexes: the right balance between cytotoxicity and siRNA effectiveness","volume":"93","author":"Lechanteur","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0155","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jconrel.2016.06.028","article-title":"Freeze-dried mucoadhesive polymeric system containing pegylated lipoplexes: towards a vaginal sustained released system for siRNA","volume":"236","author":"Furst","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.07.031_bb0160","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1002\/elps.201600249","article-title":"Capillary electrophoresis method to determine siRNA complexation with cationic liposomes","volume":"37","author":"Furst","year":"2016","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jconrel.2023.07.031_bb0165","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1529\/biophysj.107.116525","article-title":"Specific and selective peptide-membrane interactions revealed using quartz crystal microbalance","volume":"93","author":"Mechler","year":"2007","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0170","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1039\/C7MD00054E","article-title":"Effects of guanidino modified aminoglycosides on mammalian membranes studied using a quartz crystal microbalance","volume":"8","author":"John","year":"2017","journal-title":"Medchemcomm"},{"key":"10.1016\/j.jconrel.2023.07.031_bb0175","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ijpharm.2017.04.064","article-title":"Development and evaluation of injectable nanosized drug delivery systems for apigenin","volume":"532","author":"Karim","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5772\/59346","article-title":"Impact of silver nanoparticles on haemolysis, platelet function and coagulation","volume":"1","author":"Laloy","year":"2014","journal-title":"Nanobiomedicine"},{"key":"10.1016\/j.jconrel.2023.07.031_bb0185","doi-asserted-by":"crossref","first-page":"8144","DOI":"10.1021\/acs.macromol.0c01441","article-title":"Discovery of the RAFT\/MADIX process: mechanistic insights and polymer chemistry implications","volume":"53","author":"Zard","year":"2020","journal-title":"Macromolecules"},{"key":"10.1016\/j.jconrel.2023.07.031_bb0190","doi-asserted-by":"crossref","first-page":"7433","DOI":"10.1021\/acs.macromol.7b00767","article-title":"50th anniversary perspective: RAFT polymerization - a user guide","volume":"50","author":"Perrier","year":"2017","journal-title":"Macromolecules"},{"key":"10.1016\/j.jconrel.2023.07.031_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/polym14040701","article-title":"Recent advances in the synthesis of complex macromolecular architectures based on poly(N-vinyl pyrrolidone) and the RAFT polymerization technique","volume":"14","author":"Roka","year":"2022","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.jconrel.2023.07.031_bb0200","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/10601325.2021.2024076","article-title":"A short review on RAFT polymerization of less activated monomers","volume":"59","author":"Tilottama","year":"2022","journal-title":"J. Macromol. Sci. Part A Pure Appl. Chem."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0205","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1039\/b803952f","article-title":"Polymer-protein conjugates from \u03c9-aldehyde endfunctional poly(N-vinylpyrrolidone) synthesised via xanthate-mediated living radical polymerisation","author":"Pound","year":"2008","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0210","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1021\/acs.macromol.8b00770","article-title":"Thiolactone-functional reversible deactivation radical polymerization agents for advanced macromolecular engineering","volume":"51","author":"Langlais","year":"2018","journal-title":"Macromolecules"},{"key":"10.1016\/j.jconrel.2023.07.031_bb0215","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1021\/bk-2006-0944.ch038","article-title":"Various strategies for the chemical transformation of xanthate-functional chain termini in MADIX copolymers","volume":"944","author":"Destarac","year":"2006","journal-title":"ACS Symp. Ser."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0220","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.biomaterials.2015.11.056","article-title":"Effect of surface properties on liposomal siRNA delivery","volume":"79","author":"Xia","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.07.031_bb0225","first-page":"151","article-title":"Quartz crystal microbalance with dissipation monitoring: enabling real-time characterization of biological materials and their interactions","volume":"19","author":"Dixon","year":"2008","journal-title":"J. Biomol. Tech."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0230","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/BF01337937","article-title":"Verwendung von Schwingquarzen zur W\u00e4gung d\u00fcnner Schichten und zur Mikrow\u00e4gung","volume":"155","author":"Sauerbrey","year":"1959","journal-title":"Z. Phys."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0235","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jconrel.2019.08.022","article-title":"Nanomaterials meet zebrafish: toxicity evaluation and drug delivery applications","volume":"311\u2013312","author":"Jia","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.07.031_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BSR20170199","article-title":"Zebrafish models for functional and toxicological screening of nanoscale drug delivery systems: promoting preclinical applications","volume":"37","author":"Lee","year":"2017","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0245","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/acs.jnatprod.6b01019","article-title":"Antimalarial activities of alkyl cyclohexenone derivatives isolated from the leaves of Poupartia borbonica","volume":"80","author":"Ledoux","year":"2017","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0250","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.nano.2018.11.017","article-title":"Zebrafish as a predictive screening model to assess macrophage clearance of liposomes in vivo","volume":"17","author":"Sieber","year":"2019","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.06.023","article-title":"Versatile electrostatically assembled polymeric siRNA nanovectors: can they overcome the limits of siRNA tumor delivery?","volume":"567","author":"Ben Djemaa","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0260","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1242\/jcs.066399","article-title":"Breaking down the barriers: siRNA delivery and endosome escape","volume":"123","author":"Dominska","year":"2010","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0265","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.nano.2008.06.001","article-title":"Drug delivery of siRNA therapeutics: potentials and limits of nanosystems","volume":"5","author":"Reischl","year":"2009","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0270","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.nano.2013.11.018","article-title":"Preclinical development of siRNA therapeutics: towards the match between fundamental science and engineered systems","volume":"10","author":"Videira","year":"2014","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-018-2429-y","article-title":"PEG-benzaldehyde-hydrazone-lipid based PEG-sheddable pH-sensitive liposomes: abilities for endosomal escape and long circulation","volume":"35","author":"Kanamala","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0280","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.5650\/jos.ess19218","article-title":"Polyborane-encapsulated PEGylated liposomes prepared using post-insertion technique for boron neutron capture therapy","volume":"68","author":"Takeuchi","year":"2019","journal-title":"J. Oleo Sci."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0285","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1021\/acs.biomac.9b00539","article-title":"Functionalization of liposomes with hydrophilic polymers results in macrophage uptake independent of the protein corona","volume":"20","author":"Weber","year":"2019","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2023.07.031_bb0290","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.2147\/IJN.S167443","article-title":"Effects of PEG surface density and chain length on the pharmacokinetics and biodistribution of methotrexate-loaded chitosan nanoparticles","volume":"13","author":"Bachir","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.07.031_bb0295","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.1039\/c3cs60064e","article-title":"Cytokines as biomarkers of nanoparticle immunotoxicity","volume":"42","author":"Elsabahy","year":"2013","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2023.07.031_bb0300","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/s41565-021-01001-3","article-title":"The role and impact of polyethylene glycol on anaphylactic reactions to COVID-19 nano-vaccines","volume":"16","author":"Bigini","year":"2021","journal-title":"Nat. Nanotechnol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923004558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923004558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:45:30Z","timestamp":1759164330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923004558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":60,"alternative-id":["S0168365923004558"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.07.031","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Poly(vinyl pyrrolidone) derivatives as PEG alternatives for stealth, non-toxic and less immunogenic siRNA-containing lipoplex delivery","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.07.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}